Medications for Tachycardia Ventricular

32 results

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (Amiodarone Hydrochloride)
    Wockhardt Limited
    Usage: Amiodarone injection is indicated for initiating treatment and preventing recurrent ventricular fibrillation (VF) and unstable ventricular tachycardia (VT) in patients resistant to other therapies. It is also suitable for those unable to take oral amiodarone. Treatment typically lasts 48 to 96 hours or longer if needed.

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (amiodarone hydrochloride)
    Hainan Poly Pharm. Co., Ltd.
    Usage: Amiodarone injection is indicated for treating and preventing frequently recurring ventricular fibrillation (VF) and unstable ventricular tachycardia (VT) in patients unresponsive to other treatments. It is also suitable for patients who require oral amiodarone but cannot take oral medication during their acute treatment.

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (AMIODARONE HYDROCHLORIDE)
    HF Acquisition Co LLC, DBA HealthFirst
    Usage: Amiodarone hydrochloride injection is indicated for the initiation and prophylaxis of frequently recurring ventricular fibrillation and unstable ventricular tachycardia in patients refractory to other treatments. It is also suitable for patients who require oral amiodarone but cannot take oral medication. Treatment duration may vary based on patient stability.

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (Amiodarone Hydrochloride)
    Aurobindo Pharma Limited
    Usage: Amiodarone hydrochloride tablets are indicated for treating documented, life-threatening recurrent ventricular fibrillation and hemodynamically unstable tachycardia in adults unresponsive to other antiarrhythmics or when alternative treatments are not tolerated.

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (Amiodarone Hydrochloride)
    Wockhardt USA LLC.
    Usage: Amiodarone injection is indicated for the initiation of treatment and prevention of recurrent ventricular fibrillation (VF) and unstable ventricular tachycardia (VT) in refractory patients. It can also be used for patients who cannot take oral amiodarone and may transition to oral therapy once stabilized.

  • Amiodarone hydrochloride (amiodarone hydrochloride)

    (amiodarone hydrochloride)
    Zhejiang Poly Pharm. Co., Ltd.
    Usage: Amiodarone injection is indicated for initiation and prophylaxis of recurrent ventricular fibrillation and unstable ventricular tachycardia in patients not responding to other therapies. It is also used for patients who cannot take oral amiodarone. Treatment usually lasts 48 to 96 hours but may extend if needed.

  • Diltiazem hydrochloride (diltiazem hydrochloride)

    (Diltiazem Hydrochloride)
    Hikma Pharmaceuticals USA Inc.
    Usage: Diltiazem Hydrochloride Injection is indicated for temporary control of rapid ventricular rates in atrial fibrillation or flutter and for converting paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm. Continuous monitoring is essential during administration, with emergency equipment on hand.

  • Flecainide acetate (flecainide )

    (Flecainide)
    Ranbaxy Pharmaceuticals Inc.
    Usage: Flecainide is indicated for the prevention of paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. It also treats documented life-threatening ventricular arrhythmias, but it is contraindicated in post-myocardial infarction patients and not recommended for chronic atrial fibrillation.

  • Flecainide acetate (flecainide acetate tablet)

    (Flecainide Acetate Tablet)
    Bryant Ranch Prepack
    Usage: Flecainide Acetate Tablets USP are indicated for preventing paroxysmal supraventricular tachycardias (PSVT) and paroxysmal atrial fibrillation/flutter (PAF) with disabling symptoms, as well as documented life-threatening sustained ventricular tachycardia. Not recommended for patients with recent myocardial infarction or less severe ventricular arrhythmias.

  • Flecainide acetate (flecainide acetate tablet)

    (Flecainide Acetate Tablet)
    Bryant Ranch Prepack
    Usage: Flecainide Acetate Tablets USP are indicated for preventing paroxysmal supraventricular tachycardias and paroxysmal atrial fibrillation/flutter in patients without structural heart disease. They are also used for documented life-threatening sustained ventricular tachycardia. Use is not recommended in patients with recent myocardial infarction or less severe ventricular arrhythmias.